05:42 PM EST, 12/23/2024 (MT Newswires) -- Indaptus Therapeutics ( INDP ) filed a registration statement Monday with the Securities and Exchange Commission for a proposed secondary offering of about 1.94 million shares.

The company won't receive any proceeds from the planned offering by selling stockholders.

Shares of the company rose 4.6% in after-hours activity.

Price: 0.9299, Change: +0.04, Percent Change: +4.59